Currently out of the existing stock ratings of Kambiz Yazdi, 37 are a BUY (100%).

Kambiz Yazdi

Work Performance Price Targets & Ratings Chart

Analyst Kambiz Yazdi, currently employed at BTIG, carries an average stock price target met ratio of 42.31% that have a potential upside of 57.66% achieved within 190 days.

Kambiz Yazdi’s has documented 73 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on LQDA, Liquidia Technologies.

Wall Street Analyst Kambiz Yazdi

Analyst best performing recommendations are on ABSI (ABSCI CORP).
The best stock recommendation documented was for ABSI (ABSCI CORP) at 5/28/2026. The price target of $9 was fulfilled within 27 days with a profit of $2.92 (48.03%) receiving and performance score of 17.79.

Average potential price target upside

PRAX Praxis Precision Medicines ARQT Arcutis Biotherapeutics AVTX Avalo Therapeutics LQDA Liquidia Technologies VTVT vTv Therapeutics ABSI Absci Corp KZIA Kazia Therapeutics Ltd ADR EYPT Eyepoint Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 26-Mar-2024

$1201

$905.49 (306.42%)

$1201

10 days ago
(24-Sep-2026)

15/20 (75%)

$919.21 (326.20%)

286

Buy Since 24-Jun-2024

$582

$286.49 (96.95%)

$582

10 days ago
(24-Sep-2026)

15/21 (71.43%)

$300.21 (106.54%)

238

Buy Since 13-Jul-2026

$575

$279.49 (94.58%)

$447

1 months 13 days ago
(21-Aug-2026)

0/2 (0%)

$199.06 (52.95%)

Buy Since 18-Jun-2026

$462

$166.49 (56.34%)

$449

1 months 27 days ago
(07-Aug-2026)

0/2 (0%)

$101.24 (28.06%)

Hold Since 02-Feb-2026

$362

$66.49 (22.50%)

$305

1 months 27 days ago
(07-Aug-2026)

3/3 (100%)

$1.24 (0.34%)

26

Show more analysts

Please expand the browser size to see the chart

Which stock is Kambiz Yazdi most bullish on?

Potential upside of $514.49 has been obtained for PRAX (PRAXIS PRECISION MEDICINES)

Which stock is Kambiz Yazdi most reserved on?

Potential downside of -$0 has been obtained for LQDA (LIQUIDIA TECHNOLOGIES)

What Year was the first public recommendation made by Kambiz Yazdi?

On 2023
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?